Rick Coulon
Cumming, GA (USA)
Role(s):
Founder/Owner/Principal
Accuitis, Inc.
Find More Startups
Startup
Location:
Cumming
Industry:
Pharmaceuticals
Year Founded:
2012
Number Employees:
1-10 people
Business Stage:
Growth (not profitable)
Entity Type:
"C" Corporation
Description:
Accuitis, Inc. is a US registered company with commercial operations in Cumming, Ga. It is a pharmaceutical company that is engaged in the development & formulation of ophthalmic and dermatological pharmaceuticals targeting niche, orphan, & underserved ophthalmic indications. The company has acquired the rights to a portfolio of product candidates & is seeking the funding to develop three compounds. The first two are ophthalmic drugs that are currently unapproved by the FDA (grandfather status). All are widely used in the ophthalmic field but have significant benefits vs. products currently on the market.
The company’s development partner has developed unique formulations which have been validated in animal models & we intend to file patents. Accuitis intends to complete safety & efficacy trials on the grandfathered products with the FDA guidance to establish theses drug as the only approved drugs for the indications. As a result all non-approved drugs utilizing this drug substance will be required to cease being sold creating an immediate and substantial market.
We have also licensed an early stage compound which was discovered at Emory University targeting Rosacea. We intend to pursue both the dermatological and ocular forms of this disease. We have secured grant funding from the Georgia Research Alliance to conduct preclinical studies with the potential of follow-up funding.
Accuitis is seeking funding initially of $5.0 million for clinical trials, product scale-up, legal & regulatory fees, & to launch commercial activities.